GLABF (Gemina Laboratories) Days Inventory: 0.00 (As of Oct. 2025)

What is Gemina Laboratories Days Inventory?

Gemina Laboratories GLABF -27.59% Days Inventory is 0.00 as of Oct. 2025. The stock has 2 warning signs investors should review.

Days Inventory is also known as Days Sales of Inventory (DSI). Gemina Laboratories's Average Total Inventories for the three months ended in Oct. 2025 was $0.00 Mil. Gemina Laboratories's Cost of Goods Sold for the three months ended in Oct. 2025 was $0.00 Mil.

The historical rank and industry rank for Gemina Laboratories's Days Inventory or its related term are showing as below:

GLABF's Days Inventory is not ranked ^*
in the Biotechnology industry.
Industry Median: 184.145
* Ranked among companies with meaningful Days Inventory only.

Gemina Laboratories's Days Inventory stayed the same from Oct. 2024 (0.00) to Oct. 2025 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Gemina Laboratories (OTCPK:GLABF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Gemina Laboratories's Inventory Turnover for the three months ended in Oct. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Gemina Laboratories's Inventory to Revenue for the three months ended in Oct. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Gemina Laboratories Days Inventory Related Terms

Gemina Laboratories Days Inventory Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Days Inventory can be seen below:

Gemina Laboratories Days Inventory Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Jan25

Days Inventory

0.00

Gemina Laboratories Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25
Days Inventory	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

GLABF vs VRTX, REGN, ALNY: Days Inventory Comparison

For the Biotechnology subindustry, Gemina Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Days Inventory distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Days Inventory falls into.

Save Embed

Gemina Laboratories Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Gemina Laboratories's Days Inventory for the fiscal year that ended in Jan. 2025 is calculated as

	Days Inventory (A: Jan. 2025 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Jan. 2024 )	+	Total Inventories (A: Jan. 2025 ))	/	count )	/	Cost of Goods Sold (A: Jan. 2025 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Gemina Laboratories's Days Inventory for the quarter that ended in Oct. 2025 is calculated as:

	Days Inventory (Q: Oct. 2025 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jul. 2025 )	+	Total Inventories (Q: Oct. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Oct. 2025 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Inventory →

What does a Days Inventory of 0.00 mean?

Gemina Laboratories (GLABF) has a Days Inventory of 0.00 as of Oct. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gemina Laboratories and its competitors.

Is Gemina Laboratories' Days Inventory too high?

Gemina Laboratories' current Days Inventory is 0.00.

How does Gemina Laboratories' Days Inventory compare to VRTX and REGN?

Gemina Laboratories' Days Inventory of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 184.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Inventory for a Biotechnology company?

The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Inventory mean?

A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gemina Laboratories and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gemina Laboratories's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Gemina Laboratories stock overvalued right now?

Gemina Laboratories (GLABF) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Inventory calculated?

Days Inventory is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Days Inventory is 0.00 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Industry Healthcare Biotechnology

Comparable Companies XCNQ:AGN TSXV:RKV TSX:APLI XCNQ:NURL TSXV:IBO XCNQ:ASEP XCNQ:HEAL TSXV:WAVE TSXV:XRTX XCNQ:BIOV VRTX REGN XBRU:UCB XKRX:207940 ASX:CSL XBRU:ARGX ALNY ONC INSM XKRX:068270

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.